Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth [Seeking Alpha]
Strata Critical Medical, Inc. - Class A (SRTA)
Company Research
Source: Seeking Alpha
SRTA's transformation into a pure-play medical logistics provider, robust FY25 results, and margin expansion underpin confidence in forward guidance. Industry tailwinds, regulatory catalysts, and an aggressive acquisition strategy position SRTA for sustained revenue and EBITDA growth, with FY26 guidance implying an 11.6% EBITDA margin. SRTA trades at a 53% EV/EBITDA discount to peer TMDX, offering significant re-rating potential as it executes on organic and inorganic growth. Bet_Noire/iStock via Getty Images Investment Overview I am re-initiating coverage on Strata Critical Medical ( SRTA ) with a “ Buy ” rating and an investment horizon of 12 to 24 months. I believe that SRTA stock is attractively valued and This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my ow
Show less
Read more
Impact Snapshot
Event Time:
SRTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRTA alerts
High impacting Strata Critical Medical, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
SRTA
News
- Strata Critical Medical (SRTA) was upgraded by B. Riley Financial, Inc. to "strong-buy".MarketBeat
- Strata Critical Medical (SRTA) is now covered by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>. They set a "hold (c-)" rating on the stock.MarketBeat
- Strata Critical Medical (SRTA) is now covered by Craig Hallum. They set a "buy" rating and a $8.00 price target on the stock.MarketBeat
- Strata Critical Medical (SRTA) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $8.00 price target on the stock.MarketBeat
- Strata Critical Medical (SRTA) Earnings Call [Yahoo! Finance]Yahoo! Finance
SRTA
Earnings
- 11/10/25 - Beat
SRTA
Sec Filings
- 3/23/26 - Form 4/A
- 3/18/26 - Form 4
- 3/10/26 - Form 4
- SRTA's page on the SEC website